Cord blood lipid mediator profiles associated with maternal passive smoking during pregnancy
- 1Department of Pediatrics, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan
Abstract
Background: Maternal passive smoking (PS) during pregnancy remains a common environmental exposure associated with adverse perinatal outcomes. However, its effects on fetal lipid mediator profiles have not been fully characterized.
Objective: To investigate whether maternal PS during pregnancy is associated with alterations in umbilical cord blood lipid mediator profiles in term neonates.
Methods: We retrospectively analyzed umbilical cord blood samples from 56 term neonates, comprising 17 born to mothers with documented PS exposure and 39 born to mothers without PS exposure. Targeted lipid mediator profiling was performed using liquid chromatography–tandem mass spectrometry. Orthogonal partial least squares discriminant analysis, univariate analyses with Benjamini–Hochberg false discovery rate correction, receiver operating characteristic curve analysis, and exploratory multivariable linear regression were performed.
Results: Four lipid mediators showed nominal differences between the groups, with higher levels of 14,15-LTE₄, platelet-activating factor, and 13-HpODE and lower levels of oleoylethanolamide (OEA) in the PS-exposed group. However, none remained statistically significant after correction for multiple comparisons. OEA was subsequently evaluated in post-hoc exploratory multivariable analysis and remained associated with maternal PS exposure after adjustment for maternal pre-pregnancy BMI and diabetes mellitus.
Conclusions: This exploratory study identified several candidate cord blood lipid mediator signals related to maternal PS exposure, although none remained statistically significant after correction for multiple comparisons. These findings are hypothesis-generating but suggest that lipid mediator pathways involved in inflammatory and metabolic signaling may warrant further investigation in relation to prenatal tobacco smoke exposure.
Related
- Maternal HFD and CDAHFD Exposure from Pregnancy to Lactation Differentially Affect Lipid Profiles and Behavior in Offspring Mice
- Cervicovaginal lipid mediator profiles during high-risk HPV infection associated with subsequent viral clearance or persistence: an exploratory pilot study
- Maternal serum retinol, vitamin K, and ferritin profiles during pregnancy, gestational diabetes mellitus, and offspring neurodevelopment: a prospective case-control study
- Patterns of substance use during pregnancy are differentially associated with maternal mental health across the perinatal period
- Adverse pregnancy outcomes associated with advanced maternal age among Libyan women: a cross-sectional study at Benghazi medical centre
BibTeX
@article{inoue2026cord,
title = {{Cord blood lipid mediator profiles associated with maternal passive smoking during pregnancy}},
author = {Masanori Inoue and Nobuyuki Kawano and Shintaro Kishimoto and Tomoki Maeda and Kenji Ihara},
journal = {Toxicology Reports},
year = {2026},
month = oct,
doi = {10.1016/j.toxrep.2026.102359},
url = {https://doi.org/10.1016/j.toxrep.2026.102359},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Cord blood lipid mediator profiles associated with maternal passive smoking during pregnancy
AU - Masanori Inoue
AU - Nobuyuki Kawano
AU - Shintaro Kishimoto
AU - Tomoki Maeda
AU - Kenji Ihara
PY - 2026
DA - 2026/10/17
JO - Toxicology Reports
DO - 10.1016/j.toxrep.2026.102359
UR - https://doi.org/10.1016/j.toxrep.2026.102359
AB - Background: Maternal passive smoking (PS) during pregnancy remains a common environmental exposure associated with adverse perinatal outcomes. However, its effects on fetal lipid mediator profiles have not been fully characterized. Objective: To investigate whether maternal PS during pregnancy is associated with alterations in umbilical cord blood lipid mediator profiles in term neonates. Methods: We retrospectively analyzed umbilical cord blood samples from 56 term neonates, comprising 17 born to mothers with documented PS exposure and 39 born to mothers without PS exposure. Targeted lipid mediator profiling was performed using liquid chromatography–tandem mass spectrometry. Orthogonal partial least squares discriminant analysis, univariate analyses with Benjamini–Hochberg false discovery rate correction, receiver operating characteristic curve analysis, and exploratory multivariable linear regression were performed. Results: Four lipid mediators showed nominal differences between the groups, with higher levels of 14,15-LTE₄, platelet-activating factor, and 13-HpODE and lower levels of oleoylethanolamide (OEA) in the PS-exposed group. However, none remained statistically significant after correction for multiple comparisons. OEA was subsequently evaluated in post-hoc exploratory multivariable analysis and remained associated with maternal PS exposure after adjustment for maternal pre-pregnancy BMI and diabetes mellitus. Conclusions: This exploratory study identified several candidate cord blood lipid mediator signals related to maternal PS exposure, although none remained statistically significant after correction for multiple comparisons. These findings are hypothesis-generating but suggest that lipid mediator pathways involved in inflammatory and metabolic signaling may warrant further investigation in relation to prenatal tobacco smoke exposure.
SN - 2214-7500
ER -